Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin
Clinical trial NCT03631134 · UNKNOWN
Trial details
- NCT number
- NCT03631134
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-01-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.